Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Country:||Trinidad & Tobago|
|Published (Last):||11 October 2012|
|PDF File Size:||19.91 Mb|
|ePub File Size:||17.69 Mb|
|Price:||Free* [*Free Regsitration Required]|
The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- activadot cardiac thrombi in newborns.
From Monday to Friday from 9 a. Four patients had intracranial haemorrhage grade I, without sequelae at follow-up.
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. This item has received.
SJR uses a similar algorithm as the Google page rank; recombinanhe provides a quantitative and qualitative measure of the journal’s impact. Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns. Are you a health professional able to prescribe or dispense drugs? Subscribe to our Newsletter. The patients included 4 males with a mean weight of gr. March Pages ee24 Pages Subscriber If you already have your login data, please click here.
There was a problem providing the content you requested
Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. In 4 patients complete resolution of the thrombus was achieved in a mean of 3. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
SRJ is a prestige metric based on the idea that not all citations are the same. They received between 1 to 5 cycles with rTPA.
CiteScore measures average citations received per document published.
Previous article Next article. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
Continuing navigation will be considered as acceptance of this use. Si continua navegando, consideramos que acepta su uso.
You can change the settings or obtain more information by clicking here. Nine issues are published each year, including mostly originals, reviews and consensus documents. Print Send to a friend Export reference Mendeley Statistics. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation tisulqr behavior. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.
The medical records of 8 newborn were reviewed in a recoombinante study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice.
The incidence of cardiac thrombi in newborns has increased with the use of central venous recombinantd. Three patients received low molecular weight heparin prior to using rTPA.
There were no deaths or embolism.